泰地罗新注射液对自然感染猪呼吸道疾病的治疗试验

Experimental Study on the Treatment of Naturally Infected Pig Respiratory Diseases with Tildipirosin Injection

为评价泰地罗新注射液对自然感染猪呼吸道疾病的治疗效果,试验选择自然发病且表现典型的呼吸系统疾病症状的160头猪开展治疗效果试验研究。将患病猪随机分成2组,每组80头,受试组按临床推荐剂量4 mg/kg给药泰地罗新注射液,对照组按临床推荐剂量2 mg/kg给药氟苯尼考注射液。结果显示,给药之后受试组和对照组对自然感染猪呼吸道疾病的治疗成功率分别为93.75%和87.50%,相比于氟苯尼考注射液,泰地罗新注射液的疗效更好。泰地罗新注射液按照推荐剂量4 mg/kg用药,对于副猪嗜血杆菌等引发的猪呼吸道疾病具有良好、安全的治疗效果。

In order to evaluate the therapeutic effect of Tildipirosin injection on naturally infected pigs with respiratory diseases,160 pigs with naturally occurring and typical symptoms of respiratory diseases were selected for the experimental study.The infected pigs were randomly divided into 2 groups with 80 pigs in each group.The test group was given Tildipirosin injection at the clinically recommended dose of 4 mg/kg,and the control group was givenflufenicol injection at the clinically recommended dose of 2 mg/kg.The results showed that:after administration,the success rate of treatment of naturally infected swine respiratory diseases in the test group and the control group was 93.75%and 87.50%,respectively.Compared withflufenicol injection,the efficacy of Tildipirosin injection was better.Tildipirosin Injection is administered at a recommended dose of 4 mg/kg,and has a good and safe therapeutic effect on respiratory diseases in pigs caused byHaemophilusparahaemolyticusand other pathogens.